Portfolio
Synthetic Transcription Factors and Cell States for Cancer Immunotherapy
2025 Emerging Leader Award
Ansuman Satpathy, MD, PhD, Stanford University
Molecular Staples: Protein Superglues Which Disrupt Oncogenic Fusions
2025 Emerging Leader Award
Liron Bar-Peled, PhD, Mass General Cancer Center
Defining and Interrupting Microenvironment-Driven Metabolic Activity in Brain Cancer
2025 Emerging Leader Award
Daniel Wahl, MD, PhD, University of Michigan Rogel Cancer Center
Targeting the Breast Microenvironment for Cancer Immunoprevention in BRCA1 Mutation Carriers
2025 Emerging Leader Award
Kai Kessenbrock, PhD, University of California, Irvine
Identifying Spatially Conserved Programs During Tumor-Stroma Coevolution
2025 Emerging Leader Award
Mara Sherman, PhD, Memorial Sloan Kettering Cancer Center
Examining the Interplay between Chromosomal Instability and the Tumor Immune Microenvironment
ASPIRE Award (2024-Present)
Sarah McClelland, PhD, Barts Cancer Institute; Samuel Bakhoum, MD, PhD, Memorial Sloan Kettering Cancer Center; Floris Foijer, PhD, Netherlands Cancer Institute
Next-Generation Signatures of Mutational Processes Shaping Chromosomal Instability in Cancer
ASPIRE Award (2024-Present)
Florian Markowetz, PhD, CRUK Cambridge Institute at the University of Cambridge; Marcin Imieliński, MD, PhD, Weill Medical College of Cornell University; Peter Van Loo, PhD, MD Anderson Cancer Center; Roland Schwarz, PhD, Max Delbrück Center for Molecular Medicine
Targeting Translesion Polymerases as Anti-Cancer Therapeutics
ASPIRE Award (2024-Present)
Phil Hieter, PhD; Peter Stirling, PhD, University of British Columbia
Defining the Mechanism of Thrombosis in Patients with Multiple Myeloma
Damon Runyon - Mark Foundation Physician-Scientist (2024-Present)
Rebecca Zon, MD, Dana-Farber Cancer Institute
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you agree to our Terms of Use and Privacy Policy.OkPrivacy Policy and Terms of Use